novartis glp 1 drug Looming GLP-1 patent expirations draw generics firms Novo Nordisk Drops Hims &

Thats because decades of clinical research have shown that GLP-1 drugs are far superior to other diabetes medications in restoring blood sugar to optimum levels, regulating appetite and reducing blood pressure

There is a complex relationship between obesity, diabetes (particularly insulin resistance), Alzheimers, and GLP-1 agonists

For manufacturers planning to outsource these capabilities, establishing strong relationships with strategic partners well in advance could help avoid long waiting periods for a production slot

In a large phase 3 obesity trial (ACHIEVE-1), orforglipron at daily doses of 3, 12 and 36 mg caused approximately: Diarrhoea: 1926% of participants (vs 9% on placebo) Nausea: 1318% (vs 2% on placebo) Constipation: 817% (vs 4% on placebo) Vomiting: 514% (vs 1% on placebo) Across multiple studies, 617% of people stopped treatment because of side effects, mostly gut-related symptoms

doi: 10.1111/febs.16638 63 HuynhTVDavisAAUlrichJDHoltzmanDM

Sleep quality and stress management directly impact GLP-1 production and receptor function